NextCure, Inc.
Clinical-stage biopharma developing novel immunomedicines for cancer and other diseases.
NXTC | NDAQ
Overview
Corporate Details
- ISIN(s):
- US65343E1082
- LEI:
- Country:
- United States of America
- Address:
- 9000 VIRGINIA MANOR ROAD, SUITE 200, 20705 BELTSVILLE
- Website:
- https://www.nextcure.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
NextCure, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of novel, first-in-class immunomedicines to treat cancer and other diseases. The company is committed to creating therapies for patients who do not respond to or have relapsed after treatment with existing medicines. NextCure utilizes its proprietary FIND-IO® (Functional, Integrated, NextCure Discovery in Immuno-Oncology) technology platform to identify and target unique immune-related pathways to develop differentiated therapeutics.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all NextCure, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for NextCure, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for NextCure, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
